IPCA Laboratories Complete Financial Statements
IPCALAB • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for IPCA Laboratories (IPCALAB).
Downloads include all available records across all periods.
For market performance, see the
IPCALAB stock price today
.
Profitability Ratios
Net Profit Margin
10.87%
2025 data
EBITDA Margin
19.93%
2025 data
Operating Margin
19.00%
2025 data
Return on Assets
2.39%
2025 data
Return on Equity
3.35%
2025 data
Balance Sheet Ratios
Current Ratio
6.05
2025 data
Debt to Equity
1.40
2025 data
Equity Ratio
71.32%
2025 data
Asset Turnover
0.22
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Revenue Growth
+8.5%
Year-over-Year
Net Profit Growth
+14.2%
Year-over-Year
EBITDA Growth
+10.0%
Year-over-Year
Expense Growth
+8.2%
Year-over-Year
Assets Growth
+5.9%
Year-over-Year
Equity Growth
+8.6%
Year-over-Year
Liabilities Growth
+5.9%
Year-over-Year
Operating Cash Flow Growth
+39.8%
Year-over-Year
Investing Cash Flow Growth
+28.4%
Year-over-Year
Financing Cash Flow Growth
+48.8%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Jun 2018 | Dec 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2,584 | 2,273 | 2,342 | 2,381 | 2,052 | 2,113 | 2,266 | 2,073 | 1,548 | 1,630 | 2,144 | 1,637 | 1,304 | 1,608 | 1,577 | 1,563 | 1,135 | 1,587 | 1,443 | 1,377 | 1,088 | 1,547 | 1,425 | 1,299 | 895 | 1,099 | 1,231 | 1,027 | 890 | 1,020 |
| Expenses | 2,070 | 2,023 | 1,892 | 1,913 | 1,848 | 1,700 | 1,782 | 1,713 | 1,331 | 1,278 | 1,722 | 1,341 | 1,070 | 1,317 | 1,330 | 1,184 | 886 | 1,152 | 1,123 | 1,003 | 908 | 947 | 1,045 | 1,019 | 716 | 881 | 942 | 838 | 757 | 772 |
| EBITDA | 515 | 250 | 449 | 468 | 204 | 413 | 483 | 360 | 217 | 353 | 422 | 296 | 234 | 291 | 247 | 378 | 249 | 435 | 320 | 374 | 180 | 599 | 380 | 279 | 179 | 218 | 289 | 188 | 133 | 247 |
| Operating Profit Margin % | 19.00% | 10.00% | 18.00% | 19.00% | 9.00% | 19.00% | 21.00% | 16.00% | 12.00% | 19.00% | 16.00% | 16.00% | 17.00% | 17.00% | 14.00% | 23.00% | 21.00% | 26.00% | 22.00% | 26.00% | 15.00% | 38.00% | 26.00% | 21.00% | 19.00% | 18.00% | 22.00% | 17.00% | 14.00% | 23.00% |
| Depreciation | 103 | 100 | 100 | 100 | 98 | 99 | 99 | 90 | 70 | 69 | 100 | 64 | 61 | 62 | 67 | 57 | 53 | 56 | 59 | 52 | 64 | 51 | 54 | 50 | 45 | 46 | 51 | 45 | 47 | 46 |
| Interest | 20 | 22 | 19 | 23 | 29 | 24 | 17 | 44 | 19 | 31 | 33 | 9 | 3 | 7 | 11 | 1 | 2 | 2 | 1 | 2 | 4 | 3 | 2 | 4 | 6 | 5 | 4 | 2 | 5 | 5 |
| Profit Before Tax | 392 | 128 | 331 | 345 | 77 | 290 | 368 | 225 | 129 | 252 | 289 | 223 | 170 | 223 | 169 | 320 | 195 | 377 | 260 | 319 | 112 | 546 | 324 | 225 | 128 | 167 | 234 | 141 | 82 | 197 |
| Tax | 111 | 64 | 98 | 99 | 75 | 91 | 92 | 89 | 51 | 88 | 68 | 77 | 38 | 78 | 60 | 68 | 33 | 71 | 62 | 53 | 29 | 100 | 57 | 32 | 32 | 37 | 37 | 22 | 13 | 37 |
| Net Profit | 281 | 64 | 233 | 246 | 1 | 199 | 276 | 137 | 78 | 164 | 221 | 146 | 132 | 145 | 110 | 252 | 161 | 307 | 198 | 267 | 83 | 446 | 268 | 194 | 96 | 129 | 198 | 119 | 69 | 159 |
| Earnings Per Share (₹) | 11.14 | 2.67 | 9.19 | 9.05 | 2.35 | 7.58 | 9.78 | 5.72 | 3.02 | 6.42 | 7.09 | 5.67 | 5.13 | 5.64 | 4.25 | 19.73 | 12.71 | 24.18 | 7.76 | 21.11 | 6.57 | 35.27 | 21.09 | 15.32 | 7.60 | 10.24 | 15.63 | 9.38 | 5.43 | 12.59 |
Related Pages for IPCA Laboratories
Additional stock information and data for IPCALAB
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 11,761 | 11,101 | 8,626 | 7,624 | 6,068 | 5,260 | 4,551 | 4,117 | 3,960 | 3,892 | 3,812 |
| Current Assets | 5,967 | 5,539 | 5,189 | 4,447 | 3,437 | 2,856 | 2,378 | 1,946 | 1,742 | 1,622 | 1,614 |
| Fixed Assets | 4,267 | 4,553 | 2,751 | 2,402 | 2,072 | 2,059 | 1,940 | 1,953 | 1,983 | 2,014 | 1,800 |
| Capital Work in Progress | 622 | 343 | 140 | 306 | 235 | 133 | 66 | 73 | 95 | 129 | 267 |
| Investments | 980 | 862 | 626 | 989 | 505 | 310 | 120 | 87 | 136 | 26 | 0 |
| Other Assets | 5,893 | 5,343 | 5,109 | 3,926 | 3,256 | 2,758 | 2,424 | 2,005 | 1,746 | 1,723 | 1,745 |
| LIABILITIES | |||||||||||
| Total Liabilities | 11,761 | 11,101 | 8,626 | 7,624 | 6,068 | 5,260 | 4,551 | 4,117 | 3,960 | 3,892 | 3,812 |
| Current Liabilities | 986 | 1,019 | 905 | 616 | 192 | 292 | 315 | 421 | 548 | 663 | 700 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 8,388 | 7,727 | 5,915 | 5,542 | 4,716 | 3,641 | 3,138 | 2,689 | 2,455 | 2,259 | 2,208 |
| Share Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves & Surplus | 6,923 | 6,307 | 5,817 | 5,440 | 4,676 | 3,590 | 3,097 | 2,663 | 2,430 | 2,234 | 2,183 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 1,321 | 945 | 806 | 856 | 1,090 | 570 | 501 | 341 | 282 | 709 | 468 |
| Investing Activities | -870 | -1,215 | -725 | -851 | -521 | -509 | -165 | -135 | -149 | -218 | -689 |
| Financing Activities | -283 | -553 | 507 | 427 | -306 | -137 | -183 | -130 | -159 | -462 | 251 |
| Net Cash Flow | 169 | -823 | 588 | 432 | 264 | -76 | 153 | 75 | -26 | 29 | 29 |